CARDIOVASCULAR PHARMACOLOGY OF LIDOFLAZINE A LONG-ACTING CORONARY VASODILATOR

被引:0
作者
SCHAPER, WKA
XHONNEUX, R
JAGENEAU, AH
JANSSEN, PAJ
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:265 / &
相关论文
共 50 条
[21]   USEFULNESS OF LONG-ACTING NITRATES IN CARDIOVASCULAR-DISEASE [J].
ADAMS, J .
AMERICAN JOURNAL OF MEDICINE, 1978, 64 (02) :183-186
[22]   Cardiovascular effects of octreotide, a long-acting somatostatin analog [J].
Sakamoto, H .
CARDIOVASCULAR DRUG REVIEWS, 1999, 17 (04) :358-373
[23]   Long-acting opioids and cardiovascular diseases: Help or hindrance! [J].
Mehta, Ankita ;
Patel, Bhoomika M. .
VASCULAR PHARMACOLOGY, 2023, 149
[24]   FLOSEQUINAN IN CHRONIC HEART-FAILURE - SYSTEMIC AND CORONARY HEMODYNAMIC AND NEUROHUMORAL EFFECTS OF A NEW LONG-ACTING ORAL VASODILATOR [J].
DEMARCO, T ;
LIU, M ;
WOLFE, C ;
CHATTERJEE, K .
CIRCULATION, 1987, 76 (04) :444-444
[26]   Long-acting bronchodilators and risk of acute coronary syndrome [J].
Parkin, Lianne ;
Williams, Sheila ;
Sharples, Katrina ;
Barson, David ;
Horsburgh, Simon ;
Jackson, Rod ;
Dummer, Jack .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021, 50
[27]   PHARMACOLOGY OF LORATADINE (SCH-29851), A LONG-ACTING NONSEDATIVE ANTIHISTAMINE [J].
SERRANO, JJ ;
MICHEL, A ;
SAUVAIRE, D ;
ASSOULY, P .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1987, 1 (05) :400-400
[28]   TOPICS IN CLINICAL-PHARMACOLOGY - A REVIEW OF CEFTRIAXONE - A LONG-ACTING CEPHALOSPORIN [J].
STRATTON, CW ;
ANTHONY, LB ;
JOHNSTON, PE .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1988, 296 (03) :221-222
[29]   CLINICAL-PHARMACOLOGY OF LONG-ACTING BETA-RECEPTOR AGONISTS [J].
TATTERSFIELD, AE .
LIFE SCIENCES, 1993, 52 (26) :2161-2169
[30]   CORONARY VASODILATOR RESPONSES TO HYPOXIA AND INDUCED TACHYCARDIA BEFORE AND AFTER LIDOFLAZINE [J].
AFONSO, S .
AMERICAN JOURNAL OF PHYSIOLOGY, 1969, 216 (02) :297-&